Terms: = Head and neck cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
42 results:
1. DNA Damage Response Gene Signature as Potential treatment Markers for Oral Squamous Cell Carcinoma.
Pomella S; Cassandri M; Melaiu O; Marampon F; Gargari M; Campanella V; Rota R; Barillari G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768994
[TBL] [Abstract] [Full Text] [Related]
2. Drug-Loaded Acoustic Nanodroplet for Dual-Imaging Guided Highly Efficient Chemotherapy Against Nasopharyngeal Carcinoma.
Yang D; Chen Q; Zhang M; Feng G; Sun D; Lin L; Jing X
Int J Nanomedicine; 2022; 17():4879-4894. PubMed ID: 36262190
[TBL] [Abstract] [Full Text] [Related]
3. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of head and neck Squamous Cell Carcinoma.
Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
[TBL] [Abstract] [Full Text] [Related]
4. Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid cancer.
Baumgarten J; Happel C; Groener D; Staudt J; Bockisch B; Sabet A; Grünwald F; Rink T
Curr Oncol; 2022 May; 29(6):4012-4019. PubMed ID: 35735429
[TBL] [Abstract] [Full Text] [Related]
5. Comparative Clinical Efficacy of 'Concurrent Chemoradiotherapy (CCRT) and Anlotinib' Than CCRT in Patients with Locally Advanced ESCC.
Wang G; Beeraka NM; Xiao W; Zhang Y; Xue N; Chen G; Liu J; Liu Y
Technol Cancer Res Treat; 2022; 21():15330338221080939. PubMed ID: 35235470
[No Abstract] [Full Text] [Related]
6. Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
Melo GM; Guilherme LH; Palumbo MDN; Rosano M; Neves MCD; Callegari FM; Abrahao M; Cervantes O
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S152-S162. PubMed ID: 35042657
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of the pre-treatment functional MRI metrics' efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy.
Zhao DW; Fan WJ; Meng LL; Luo YR; Wei J; Liu K; Liu G; Li JF; Zang X; Li M; Zhang XX; Ma L
Cancer Imaging; 2021 Nov; 21(1):59. PubMed ID: 34758876
[TBL] [Abstract] [Full Text] [Related]
8. Indurated Plaques on the Legs: Think Lymphoma.
Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
[TBL] [Abstract] [Full Text] [Related]
9. Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy.
Fujita K; Motoyama S; Sato Y; Wakita A; Nagaki Y; Minamiya Y; Miura M
Esophagus; 2022 Jan; 19(1):146-152. PubMed ID: 34347217
[TBL] [Abstract] [Full Text] [Related]
10. Surgical interventions for management of benign parotid tumors: Systematic review and network meta-analysis.
Mashrah MA; Al-Sharani HM; Al-Aroomi MA; Abdelrehem A; Aldhohrah T; Wang L
Head Neck; 2021 Nov; 43(11):3631-3645. PubMed ID: 34288212
[TBL] [Abstract] [Full Text] [Related]
11. Adoptive γδT-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancer.
Sato Y; Mori K; Hirano K; Yagi K; Kobayashi Y; Nagaoka K; Hosoi A; Matsushita H; Kakimi K; Seto Y
Cytotherapy; 2021 May; 23(5):423-432. PubMed ID: 33781711
[TBL] [Abstract] [Full Text] [Related]
12. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract] [Full Text] [Related]
13. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Different Laser-Supported Surgical Protocols for the treatment of Oral Leukoplakia: A Long-Term Follow-Up.
Nammour S; Zeinoun T; Namour A; Vanheusden A; Vescovi P
Photomed Laser Surg; 2017 Nov; 35(11):629-638. PubMed ID: 28426376
[TBL] [Abstract] [Full Text] [Related]
15. Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
McDowell LJ; Huang SH; Xu W; Che J; Wong RKS; Brierley J; Kim J; Cummings B; Waldron J; Bayley A; Hansen A; Witterick I; Ringash J
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):186-195. PubMed ID: 28258892
[TBL] [Abstract] [Full Text] [Related]
16. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
[TBL] [Abstract] [Full Text] [Related]
17. A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
Tol JP; Doornaert P; Witte BI; Dahele M; Slotman BJ; Verbakel WF
Radiother Oncol; 2016 May; 119(2):337-43. PubMed ID: 27130730
[TBL] [Abstract] [Full Text] [Related]
18. Facial paralysis after superficial parotidectomy: analysis of possible predictors of this complication.
Bittar RF; Ferraro HP; Ribas MH; Lehn CN
Braz J Otorhinolaryngol; 2016; 82(4):447-51. PubMed ID: 26777078
[TBL] [Abstract] [Full Text] [Related]
19. Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy.
Tanaka Y; Aoyagi K; Minashi K; Komatsuzaki R; Komatsu M; Chiwaki F; Tamaoki M; Nishimura T; Takahashi N; Oda I; Tachimori Y; Arao T; Nishio K; Kitano S; Narumi K; Aoki K; Fujii S; Ochiai A; Yoshida T; Muto M; Yamada Y; Sasaki H
PLoS One; 2015; 10(12):e0143804. PubMed ID: 26625258
[TBL] [Abstract] [Full Text] [Related]
20. Influence of genetic background and oxidative stress response on risk of mandibular osteoradionecrosis after radiotherapy of head and neck cancer.
Danielsson D; Brehwens K; Halle M; Marczyk M; Sollazzo A; Polanska J; Munck-Wikland E; Wojcik A; Haghdoost S
Head Neck; 2016 Mar; 38(3):387-93. PubMed ID: 25352150
[TBL] [Abstract] [Full Text] [Related]
[Next]
